Abstract

e12645 Background: Gastric cancer (GC) remains a common malignancy in Turkey despite its decreasing incidence in recent years. Studies investigating the clinical and biologic features of gastric ca...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Impacts of the Coronavirus 2019 Pandemic on Gastrointestinal Endoscopy Volume and Diagnosis of Gastric and Colorectal Cancers: A Population-Based Study
Kathy Leung ... Thomas K.L Lui
Gastroenterology | VOL. 159
Kathy Leung, et. al.Kathy Leung ... Thomas K.L Lui
17 May 2020
Covering the Cover
Richard H Moseley ... Anson W Lowe
Gastroenterology | VOL. 143
Richard H Moseley, et. al.Richard H Moseley ... Anson W Lowe
22 Aug 2012
Expectations for and challenges in population-based endoscopic gastric and colorectal cancer screening.
Takahisa Matsuda
Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society | VOL. Suppl 34 2
Takahisa MatsudaTakahisa Matsuda
27 Jun 2021
Clinical features and cancer risk in families with pathogenic CDH1 variants irrespective of clinical criteria
Xavier Llor ... Rosa M Xicola
Journal of Medical Genetics | VOL. 56
Xavier Llor, et. al.Xavier Llor ... Rosa M Xicola
11 Jul 2019
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes
Cristina Astrid Tentori ... Fabio Ciceri
Journal of Clinical Oncology | VOL. -
Cristina Astrid Tentori, et. al.Cristina Astrid Tentori ... Fabio Ciceri
09 May 2024
Addressing Disability in Cancer Survivors
Rachelle Brick ... Emily S Tonorezos
Journal of Clinical Oncology | VOL. -
Rachelle Brick, et. al.Rachelle Brick ... Emily S Tonorezos
09 May 2024
First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study
Susanna Hegewisch-Becker ... Niall C Tebbutt
Journal of Clinical Oncology | VOL. -
Susanna Hegewisch-Becker, et. al.Susanna Hegewisch-Becker ... Niall C Tebbutt
09 May 2024
A pivotal phase 2 single-arm study of glecirasib (JAB-21822) in patients with NSCLC harboring KRAS G12C mutation.
Yuankai Shi ... Zhengbo Song
Journal of Clinical Oncology | VOL. 42
Yuankai Shi, et. al.Yuankai Shi ... Zhengbo Song
30 Apr 2024
View more papers